Answers are grounded in this paper and cite their sources.
Case report details tissue edema linked to mivacurium chloride in endoscopic thyroidectomy, highlighting anesthetic considerations.
Abstract Background Recently, endoscopic thyroid surgeries have gained popularity for the treatment of thyroid tumors. Mivacurium chloride is a highly selective non-depolarizing neuromuscular blocking agent that with a short duration of action. Due this advantage, mivacurium is used for endoscopic thyroid surgeries requiring neuromonitoring. However, mivacurium-related histamine release is a side-effect to be considered in these procedures. Case presentation Here we report two cases of clearly discernable tissue edema and fluid exudation during endoscopic thyroidectomy associated with mivacurium administration in two patients. Although they received mivacurium doses less than recommended, their blood pressure decreased > 30% after induction and during anesthesia. In both cases, the thyroid gland demonstrated overt edema with continuous fluid exudation during the procedure thereby affecting the surgeon’s field of vision. Conclusions Due to anatomical limitations and limited space in the neck, the use of mivacurium may contribute to overt edema affecting the surgeon’s field of vision. Anesthesiologists should be vigilant on the selection and use of neuromuscular blocking agents during the various types of endoscopic thyroid surgery approaches.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: